Antibe Therapeutics Inc(Pre-Merger) T.ATE

Stopping osteoarthritis

[MasterAlgae]

Antibe posted the link below on their twitter feed about Canakinumab stopping osteoarthritis.

This drug is very expensive (right now) and has immune system side-effects, it's the property of Novartis Pharmaceuticles. It is in exploratory analysis stage. Imagine if Novartis could stop osteoarthritis!

We all know there is a need.

https://www.health.harvard.edu/blog/stopping-osteoarthritis-could-recent-heart-research-provide-a-clue-2020101521157

[MrMugsy]

Isn’t that the one Merck sold to them recently for $50 euro upfront and $400M euro later ? Knee injectable 

[Doccole]

I wonder what Antibe is asking for? Wallace and Ceo Dan being older, I wonder if they're trying to unload the whole line.

[MrMugsy]

I have been told that they will entertain any type of offer ... up to and including the sale of the entire company. Keep in mind, that also include multiple partners in multiple geographies as an option as well.

[Doccole]

Do you know of any examples of pharmaceutical companies that are partnered with biotech companies in different geographies?

[MrMugsy]

If I understand your question Doccole, I follow a small cancer company out of Calgary on the immunotherapy side - Quest Pharmatech (QPT.V). They are partnered in China, USA and South Korea with different drug candidates but probably in different ways than you might be asking. One similarity though, is a recent IP sale to a South Korean company and the new owners are responsibe for taking this

[Doccole]

Sure does! I appreciate the insight